Nolvadex vs Clomid vs Enclomiphene
The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.
Nolvadex (Tamoxifen) | Clomid (Clomiphene Citrate) | Enclomiphene (Androxal) | |
|---|---|---|---|
| What it is | Prescription breast cancer medicine (a SERM) that is also used after anabolic steroids to restart the body's own testosterone production. | Prescription fertility medicine for women; men use it off-label to raise testosterone, and it can cause mood problems. | Unapproved testosterone-boosting compound: a cleaner version of Clomid, developed for low hormone levels in men. |
| MechanismMechanism of actionThe molecular pathway by which a compound acts in the body (e.g. which receptor or enzyme it binds). | Non-steroidal SERM, ER-α competitive antagonist at pituitary + breast | Non-steroidal SERM, racemic mixture (62% zuclo + 38% enclo) | Estrogen receptor blocker; without the mood-disturbing form of clomiphene |
| Dosing (PCT) | 20-40 mg/day, 4-6 weeks | 50 mg/day × 1-2 weeks, then 25 mg/day × 2-4 weeks | — |
| Half-lifeHalf-lifeThe time for the compound’s plasma concentration to fall by half; indicates how fast it clears and how often it is dosed. | ~5-7 days (parent) / ~14 days (4-OH-tamoxifen active metabolite) | Zuclomiphene ~5-7 weeks accumulating / enclomiphene ~5 days | ~5 days (cleaner than Clomid mixed t1/2) |
| OnsetOnsetThe time from dosing until a measurable effect appears. | LH rise within 24-72 h, Test recovery 2-3 weeks | LH rise 5-10 days, Test recovery 3-4 weeks | LH rise 24-72 h, Test recovery 2-4 weeks |
| Legal statusLegal / WADA statusThe compound’s regulatory status (e.g. prescription) and its place on the WADA prohibited-in-sport list. | FDA + EMA Rx, registered in HU + PL, WADA S4 (banned in-competition) | FDA + EMA Rx (female indication), off-label male hypogonadism, WADA S4 (banned) | NOT FDA-approved (CRL 2016), US-compounding + EU research-pharm + UGL |
| Dosing (PCT or hypogonadism) | — | — | 12.5-25 mg/day, morning |
| Full entry | Open → | Open → | Open → |
Nolvadex, Clomid or enclomiphene: what tells them apart?
All three catch the oestrogen signal at the pituitary, which releases LH and FSH and lets the body's own testosterone production restart. Clomid and enclomiphene are two forms of the same molecule: Clomid is a mixture in which the second, slowly accumulating half is mildly oestrogen-like, and that half is what the entry puts behind its characteristic mood effects; enclomiphene is the same molecule without that half, but it never received approval. Nolvadex is a separate molecule with by far the longest clinical record, and besides the pituitary it also blocks the oestrogen receptor in breast tissue.
